Experiment: 7SXD

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
2	2D 1H-13C HSQC	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
3	3D CBCA(CO)NH	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
4	3D CBCANH	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
5	3D HBHA(CO)NH	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
6	3D HNCO	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
7	3D 1H-15N NOESY	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
8	3D 1H-13C NOESY aliphatic	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
9	3D 1H-13C NOESY aliphatic	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800
10	3D 1H-13C NOESY aromatic	1 mM [U-13C; U-15N] TnC-TnI chimera	95% H2O/5% D2O	50 mM	7.2	1 atm	293	Bruker AVANCE III HD 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	800

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	TopSpin	3.0	Bruker Biospin
2	chemical shift assignment	AutoAssign	2.3.0	Zimmerman, Moseley, Kulikowski and Montelione
3	peak picking	XEASY	1.5.5	Bartels et al.
4	refinement	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
5	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.